Related Experiment Videos
Dye rashes.
S S Raimer1, E M Quevedo, R V Johnston
1Department of Anesthesiology, University of Texas Medical Branch, Galveston 77555-0591, USA.
Cutis
|March 11, 1999
Summary
Intravenous dyes like fluorescein and methylene blue can cause unexpected skin reactions. Physicians should be aware of these potential hazards, including colorful urticaria and macules, following dye administration.
Area of Science:
- Medical Diagnostics
- Dermatology
- Pharmacology
Background:
- Intravenous dyes are frequently used in medical settings for diagnostic purposes, such as visualizing vascular and urinary systems.
- The potential adverse effects of these dyes, particularly cutaneous reactions, are not always fully recognized by healthcare providers.
- Understanding dye-induced dermatological responses is crucial for patient safety and accurate diagnosis.
Observation:
- Two distinct cases of adverse skin reactions following intravenous dye administration are presented.
- The first case involved a patient who developed yellowish, fluorescent urticaria post-fluorescein administration.
- The second case demonstrated rapid-onset, painful blue macules on the forearm after methylene blue injection.
Findings:
- The observed skin eruptions directly corresponded in color to the administered intravenous dyes.
- Fluorescein administration led to a yellow, UV-reactive urticarial rash.
- Methylene blue injection resulted in immediate, painful blue macules, indicating a localized vascular or dermal reaction.
Implications:
- These cases highlight the importance of recognizing and managing potential dermatological side effects of common intravenous dyes.
- Clinicians should inform patients about the possibility of skin reactions, including color changes, after dye administration.
- Further investigation into the mechanisms of dye-induced cutaneous reactions may improve patient safety protocols.